News
35m
BOSTON, April 28, 2025--nChroma Bio ("nChroma"), a genetic medicines company advancing programmable in vivo delivery to overcome the limitations of existing therapies, today announced the acceptance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback